Get the Stockscreener App
1.47
3.29%
-0.05
Pre-market:
1.46
-0.01
-0.68%
Alector Inc stock is traded at $1.47, with a volume of 4.42M.
It is down -3.29% in the last 24 hours and down -50.34% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$1.52
Open:
$1.52
24h Volume:
4.42M
Relative Volume:
1.76
Market Cap:
$148.78M
Revenue:
$100.56M
Net Income/Loss:
$-119.05M
P/E Ratio:
-1.1951
EPS:
-1.23
Net Cash Flow:
$-231.16M
1W Performance:
-2.00%
1M Performance:
-50.34%
6M Performance:
+22.50%
1Y Performance:
-70.12%
1-Day Range:
$1.40
$1.56
1-Week Range:
$1.40
$1.68
52-Week Range:
$0.87
$6.14
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Compare ALEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.47 | 153.84M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-22-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-22-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-22-25 | Downgrade | Mizuho | Outperform → Neutral |
| Oct-22-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-28-25 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-17-24 | Downgrade | Mizuho | Outperform → Neutral |
| Dec-16-24 | Downgrade | Stifel | Buy → Hold |
| Dec-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-29-24 | Reiterated | H.C. Wainwright | Buy |
| Nov-26-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Dec-14-23 | Upgrade | Stifel | Hold → Buy |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Sep-25-23 | Initiated | Goldman | Sell |
| Sep-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Is Alector Inc. (0Z2) stock resilient in recession scenariosSwing Trade & High Conviction Investment Ideas - newser.com
Volatility clustering patterns for Alector Inc.July 2025 PostEarnings & Real-Time Volume Trigger Notifications - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Alector, Inc. (ALEC) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
How to track smart money flows in Alector Inc.Weekly Trade Review & Real-Time Stock Movement Alerts - newser.com
Why Alector Inc. (0Z2) stock attracts wealthy investorsQuarterly Portfolio Review & Advanced Swing Trade Entry Plans - newser.com
How Alector Inc. (0Z2) stock compares with market leadersPortfolio Value Report & AI Powered Market Trend Analysis - newser.com
Backtesting results for Alector Inc. trading strategies2025 Institutional Moves & AI Powered Buy and Sell Recommendations - newser.com
Is Alector Inc. (0Z2) stock supported by strong fundamentalsJuly 2025 Gainers & Expert Approved Momentum Trade Ideas - newser.com
Will Alector Inc. stock maintain dividend yieldPortfolio Performance Summary & Fast Entry High Yield Tips - newser.com
Why Alector Inc. stock attracts global investorsJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
Alector, Inc. (ALEC) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Alector, Inc. (ALEC) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Alector, Inc. (ALEC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2025-10-31 | Alector, Inc. (ALEC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ALEC | Press Release - Stockhouse
Will Alector Inc. stock attract ESG investors2025 Technical Overview & Accurate Entry and Exit Point Alerts - newser.com
Is Alector Inc. stock a defensive play in 2025Quarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Can Alector Inc. (0Z2) stock hold up in economic slowdown2025 Short Interest & Accurate Technical Buy Alerts - newser.com
Alector Announces Topline Results from Phase 3 INFRONT-3 Clinical Trial Evaluating Latozinemab - Insider Monkey
How to build a dashboard for Alector Inc. stock2025 Year in Review & Verified Stock Trade Ideas - newser.com
Evaluating Alector Inc. with trendline analysisJuly 2025 Trends & Verified Momentum Watchlists - newser.com
Is Alector Inc a good long term investmentTrend Following Strategies & High Return Trading Portfolio - earlytimes.in
Alector’s Latozinemab Study: A Promising Continuation for Neurodegenerative Disease Treatment - TipRanks
Bronstein, Gewirtz & Grossman, LLC Is Investigating Alector, Inc. (ALEC) And Encourages Investors to Connect - ACCESS Newswire
10 Best Stocks Under $3 to Invest In - Insider Monkey
Alector’s Phase 3 Trial of Latozinemab Fails to Meet Efficacy Endpoints in FTD-GRN Study - MyChesCo
Alector (ALEC) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Has Alector Inc. found a price floorPortfolio Risk Summary & Safe Entry Trade Signal Reports - newser.com
Alector (ALEC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Yahoo Finance
Alector (ALEC) Price Target Decreased by 42.61% to 2.24 - MSN
Is Alector Inc. stock attractive for ETFs2025 Earnings Impact & Advanced Swing Trade Entry Plans - fcp.pa.gov.br
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alector, Inc.ALEC - MarketScreener
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alector, Inc.ALEC - WV News
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):